Table 4. Financial and Economic per Person Treated.
| Country | Year | MDA round | Population at Risk in Current MDA Areas | Population Treated | Financial Cost ($US) | Financial per Person Treated ($US) | Economic Cost per Person Treated ($US) | MDA Coverage Rate (%) |
| Albendazole+Mectizan | ||||||||
| Burkina Faso | 2001 | 1 | 559,000 | 431,399 | $46,000 | 0.11 | 4.55 | 77% |
| Burkina Faso | 2002 | 2 | 2,613,000 | 1,801,125 | $110,000 | 0.06 | 4.82 | 69% |
| Ghana | 2002 | 2 | 1,650,000 | 1,223,122 | $1,358,000 | 0.17 | 4.88 | 69% |
| Tanzania | 2000 | 1 | 40,800 | 37,000 | $20,000 | 0.54 | 5.16 | 91% |
| Tanzania | 2001 | 2 | 182,000 | 118,220 | $50,000 | 0.42 | 5.82 | 65% |
| Tanzania | 2002 | 3 | 537,000 | 437,698 | $118,000 | 0.27 | 4.56 | 82% |
| Tanzania | 2003 | 4 | 687,000 | 511,671 | $133,000 | 0.26 | 4.53 | 75% |
| Albendazole+DEC | ||||||||
| Dominican Republic | 2002 | 1 | 142,000 | 115,411 | $216,000 | 1.87 | 3.10 | 83% |
| Dominican Republic | 2003 | 2 | 333,000 | 250,059 | $217,000* | 0.87* | 1.56* | 75% |
| Egypt | 2000 | 1 | 2,088,000 | 1,795,553 | $2,412,000 | 1.37 | 1.80 | 86% |
| Egypt | 2001 | 2 | 2,638,000 | 2,320,602 | $3,109,000 | 1.00 | 1.34 | 87% |
| Haiti (Leogane) | 2000 | 1 | 150,000 | 105,750 | $236,000 | 2.23 | n/a | 71% |
| Haiti (Leogane) | 2001 | 2 | 150,000 | 79,713 | $156,000 | 1.96 | n/a | 53% |
| Haiti (Leogane) | 2002 | 3 | 150,000 | 121,139 | $158,000 | 1.30 | n/a | 81% |
| Haiti (Milot) | 2002 | 1 | 126,000 | 100,376 | $110,000 | 1.10 | n/a | 79% |
| Philippines | 2003 | 3 | 691,000 | 556,912 | $105,842 | 0.19 | 0.40 | 81% |
*
Adjusted for peso devaluation.